Does TALAZOPARIB Cause Haemoglobin decreased? 65 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Haemoglobin decreased have been filed in association with TALAZOPARIB (Talzenna). This represents 4.4% of all adverse event reports for TALAZOPARIB.
65
Reports of Haemoglobin decreased with TALAZOPARIB
4.4%
of all TALAZOPARIB reports
1
Deaths
24
Hospitalizations
How Dangerous Is Haemoglobin decreased From TALAZOPARIB?
Of the 65 reports, 1 (1.5%) resulted in death, 24 (36.9%) required hospitalization, and 6 (9.2%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TALAZOPARIB. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does TALAZOPARIB Cause?
Anaemia (219)
Neoplasm progression (169)
Death (142)
Off label use (78)
Thrombocytopenia (78)
Fatigue (77)
Platelet count decreased (68)
Febrile neutropenia (60)
Pancytopenia (60)
Nausea (53)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which TALAZOPARIB Alternatives Have Lower Haemoglobin decreased Risk?
TALAZOPARIB vs TALC
TALAZOPARIB vs TALIGLUCERASE ALFA
TALAZOPARIB vs TALIMOGENE LAHERPAREPVEC
TALAZOPARIB vs TALQUETAMAB
TALAZOPARIB vs TALQUETAMAB-TGVS